Stimulating the right pitch at the right rate and at the right place in the cochlea enables people with hearing loss to hear with their cochlear implants in a way that comes uniquely close to natural hearing. Simple, right? Not at all. MED-EL’s sophisticated technology that enables closest to natural hearing is anything but simple. Read on to find out what sets us apart from other CI manufacturers and why we are the worldwide leader when it comes to cochlear implant sound quality.

Prof. Dr. Philippe Lefèbvre and Prof. Dr. Joachim Müller share their experiences leading the feasibility study on MED-EL’s Totally Implantable Cochlear Implant (TICI), breakthrough technology that integrates all cochlear implant components—audio processor, microphone, and battery—into one device under the skin.

There is growing evidence that cochlear implant recipients may benefit more from their devices if tonotopic mismatch is reduced. After providing an overview of recent research on tonotopic mismatch, this article explores how researchers and clinicians have been working to reduce tonotopic mismatch and improve hearing outcomes for MED-EL cochlear implant recipients.

A cochlear implant electrode serves not only as a crucial bridge between technology and nature that connects recipients to sound. The electrode array can significantly impact hearing outcomes. For instance, there is now growing consensus among researchers that stimulating more of the cochlea is associated with better speech perception and music appreciation. Here is the latest research you need to know to ensure each of your patients can benefit the most from their cochlear implant.